SwiftX™ Sepsis (RUO) from up to 10 ml of blood - 20 extractions

ULTRASENSITIVE DNA EXTRACTION FROM WHOLE BLOOD
SwiftX™ Sepsis redefines rapid pathogen DNA extraction for bloodstream infection research and diagnostics, from bacteremia to fungemia

IN SEPSIS, SPEED IS SURVIVAL.
FROM DAYS TO HOURS. REVOLUTIONIZING BACTEREMIA AND FUNGEMIA DETECTION WORKFLOWS.
Culture-based identification can delay effective therapy. SwiftX™ Sepsis enables molecular detection of bacteremia and fungemia directly from whole blood within hours, supporting early pathogen identification and faster clinical decision-making.

CAPTURE. PURIFY. ANALYZE. ULTRASENSITIVE AND FAST PATHOGEN DETECTION.
SwiftX™ Sepsis (RUO) delivers pathogen DNA from whole blood in under 45 minutes, yielding PCR- and qPCR-ready DNA from bacterial and fungal targets for rapid downstream analysis.
Co-developed with academic and clinical partners, it pairs cell capture with proprietary reverse purification, enriching samples with low pathogen load and preserving low-copy targets.

FASTER ANSWERS. TARGETED THERAPY. BETTER OUTCOMES.
SwiftX™ Sepsis bridges molecular research and clinical application. Once CE-IVD marked, it can support informed decisions by clinicians on optimized antibiotic and antifungal therapy long before culture-based results arrive.Intended purpose

Designed for Infectious Disease and AMR Research
- Developed with infectious disease specialists, SwiftX™ Sepsis enables rapid, culture-free pathogen DNA extraction directly from whole blood.
- Ideal for bacteremia, fungemia, and sepsis-related research, host–pathogen studies, and AMR surveillance, it accelerates molecular characterization and supports early, data-driven antimicrobial decisions.
- For research use only (RUO). CE-IVD coming soon.
- “SwiftX™ Sepsis empowers researchers with a fast, precise microbial DNA extraction platform in real-time.” — Dr. Andy Wende, CEO and Head of R&D, Xpedite Diagnostics

BROAD DOWNSTREAM COMPATIBILITY
SwiftX™ Sepsis delivers clean, inhibitor-free nucleic acids in less than 45 minutes compatible with PCR and qPCR (single-plex or multiplex)

SIMPLIFIED. AUTOMATABLE. HIGH-YIELD WORKFLOW.
Capture whole bacterial cells. Lyse. Purify. Detect. With SwiftX™ Sepsis, skip spin columns troubles.
Minimal handling, maximum recovery:

- Input: up to 10 mL whole blood
- Hands-on: <10 min
- Total time: ~45 min
- Equipment: magnetic rack, heating blocks (65 °C / 95 °C), vortexer

Automation-ready: compatible with open bench-top liquid handlers and our upcoming SwiftXtractor™

VALIDATED ON BACTERIAL AND FUNGAL PATHOGENS
SwiftX™ Sepsis (RUO) performance validation was carried out using clinically relevant Gram-positive, Gram-negative, and fungal pathogens, including E. coli, K. pneumoniae, S. pneumoniae, P. aeruginosa, S. aureus, E. faecalis, and C. albicans.
Paired extraction and qPCR results demonstrated consistent detection across all tested species, confirming robust yield and reproducibility from µL to 10 mL whole-blood inputs.
With optimized qPCR assays, SwiftX™ Sepsis unlocks ultra high sensitivity by enabling extraction from 10mL and detection of below 10 cfu/mL of whole blood.

SIMPLER TRAINING. ENABLING CULTURE-FREE SEPSIS RESEARCH ANYWHERE.
SwiftX™ Sepsis simplifies culture-free DNA extraction with a magnet-based workflow that requires no centrifuge or complex training. From hospital labs to decentralized research sites, it enables rapid molecular analysis directly from whole blood where speed and access are critical.

ENVIROMENTAL FRIENDLY DNA EXTRACTION
Free from hazardous chemicals and less plastic usage, SwiftX™ Sepsis reduces environmental impact, supporting sustainable future in research and diagnostics.

Documentation:>
IFU - SwiftX™ Sepsis
Insert - SwiftX™ Sepsis